Two drugmakers to be made public by FTC
Published: 2012-01-06 07:00:00
Updated: 2012-01-06 07:00:00
Korea’s antitrust regulator announced Wednesday that Myungmoon Pharmaceutical Co. was found to have provided 3.6 billion won to doctors and hospitals in return for prescribing, purchasing or recommending their products, as a result of its probe since October 2010.
The Fair Trade Commission is ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
